Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Protein Corona Effects on Nanoparticle Function

    2026-09-25

    Protein Corona Effects on Nanoparticle Function

    Nanoparticles do not encounter cells as chemically unchanged objects. In biological fluids, proteins and other biomolecules associate with their surfaces, creating a protein corona that can influence how particles interact with cells and where their cargo goes. Elizabeth Voke’s dissertation, The Influence of Protein Corona Formation on Nanoparticle Functionality, examines this interface across plant and mammalian contexts, with experimental work focused on lipid nanoparticles (LNPs) in human plasma and liver-derived cells. Its practical contribution is both methodological and interpretive: it offers a strategy for identifying LNP-associated proteins and shows why particle uptake alone is an incomplete measure of delivery success.

    Study Background and Research Question

    Engineered nanoparticles are being developed for delivery and sensing in biological systems, but their intended performance can change after exposure to a complex environment. The corona that forms on a particle may affect its interactions with cell membranes and receptors, and therefore its distribution, uptake, and downstream activity. Understanding that interface is important for interpreting nanoparticle experiments and improving translation beyond controlled laboratory conditions.

    The dissertation addresses two connected challenges. First, how can researchers characterize a corona on lipid-based particles when the biofluid already contains endogenous nanoparticles that complicate particle isolation? Second, do proteins enriched on LNPs change delivery-related outcomes, and are those outcomes captured by measuring uptake alone? The work places these questions alongside a broader discussion of nanoparticle-based plant sensors, where biological barriers and analytical challenges also shape performance. The mammalian LNP experiments provide the principal functional evidence described in the dissertation abstract.

    Key Innovation from the Reference Study

    The methodological innovation is a quantitative, label-free mass spectrometry-based proteomics workflow designed for LNPs exposed to pooled human blood plasma. The approach combines density gradient ultracentrifugation to isolate LNP-associated material with proteomic normalization intended to account for native nanoparticles in the plasma. This is important because a protein detected in an isolated fraction cannot automatically be assumed to have been specifically enriched on the experimental LNP; endogenous particles can contribute proteins to the same sample.

    The dissertation then connects corona composition to function rather than treating proteomic identification as an endpoint. It examines selected proteins found consistently enriched in the LNP corona and evaluates whether pre-incubation with these proteins changes cellular uptake, intracellular trafficking, or mRNA expression. This design helps separate two questions often conflated in delivery studies: whether particles enter cells and whether their cargo yields a measurable functional output.

    Methods and Experimental Design Insights

    In the mammalian experimental component, LNPs were exposed to pooled human plasma, and a density-gradient separation workflow was used to recover LNP-associated proteins for mass spectrometry. Proteomic normalization was incorporated to address the background contribution of native biofluid nanoparticles. The resulting analysis identified apolipoprotein E, vitronectin, alpha-2-macroglobulin, and C-reactive protein among the proteins consistently enriched in the LNP corona, as reported in the dissertation’s abstract and findings.

    For functional follow-up, the dissertation examined LNPs pre-incubated with these enriched proteins in HepG2 liver cells. Confocal microscopy image analysis and flow cytometry were used to assess cell uptake, while lysosomal trafficking and mRNA expression were also considered. These complementary readouts matter because uptake, intracellular routing, and expression represent distinct stages in a delivery pathway. A particle can be internalized without delivering its RNA to a cellular compartment that supports productive expression.

    Protocol Parameters

    • Corona formation: The study exposed LNPs to pooled human blood plasma before isolating LNP-associated material; the dissertation abstract does not provide numerical incubation conditions.
    • Particle-associated proteomics: Density gradient ultracentrifugation and quantitative, label-free mass spectrometry were used to characterize the corona, with normalization to address endogenous plasma nanoparticles.
    • Functional follow-up: Selected enriched proteins were used in LNP pre-incubation experiments, followed by uptake, lysosomal-trafficking, and mRNA-expression assessments in HepG2 cells.
    • Workflow consideration: For replication or adaptation, researchers should define plasma handling, separation, and normalization procedures for their own particle and biofluid system; these choices should not be inferred from the abstract alone.
    • Readout selection: Pair a measure of cellular association or uptake with a cargo-function readout. This is a design recommendation drawn from the study’s central result, not a reported numerical protocol setting.

    Core Findings and Why They Matter

    The key functional result is that increased cell uptake did not reliably correspond to increased mRNA expression. In particular, LNPs pre-incubated with apolipoprotein E showed higher uptake and increased lysosomal trafficking, but no change in mRNA expression. The dissertation presents lysosomal routing as a possible explanation for the disconnect: more particle signal inside a cell does not necessarily mean that more RNA reaches a productive expression pathway. This interpretation is supported by the observed trafficking differences, but it should not be read as proof that lysosomal trafficking is the sole cause.

    The finding has direct implications for experimental design. If an LNP study uses uptake as its only endpoint, it may classify a condition as improved even when expression is unchanged. Conversely, an expression assay alone may show a difference without revealing whether it arose from altered internalization or events after uptake. Combining imaging or flow-cytometric uptake measurements with trafficking and expression readouts can help distinguish these possibilities.

    The protein-specific experiments also shift attention from bulk corona formation to the identity and functional effects of enriched proteins. The work examined apolipoprotein E, vitronectin, alpha-2-macroglobulin, and C-reactive protein, but the abstract’s clearest reported functional example is apolipoprotein E. It would therefore be premature to assign the same uptake or expression effects to every identified protein. The broader contribution is a framework for asking which corona components matter for a defined particle and cellular outcome.

    Comparison with Existing Internal Articles

    An internal overview of dual-mode reporter mRNA applications discusses fluorescent tracking alongside bioluminescent expression readouts. That topic is relevant to assay planning because the dissertation shows why uptake and functional expression should not be treated as interchangeable. The two resources address different questions, however: the dissertation provides evidence about plasma-derived corona effects on LNP behavior, while the internal overview concerns reporter-based measurement options. The latter is a workflow companion, not evidence for the dissertation’s corona findings.

    Limitations and Transferability

    The mammalian functional work is centered on pooled human plasma and HepG2 liver cells. Those choices support a focused examination of plasma-conditioned LNPs in a liver-derived cell model, but they do not establish that the same corona composition or functional effects occur in other biofluids, cell types, tissues, or organisms. Corona formation depends on the particle and biological environment, so transfer to a new system requires direct characterization rather than assuming that the reported protein profile will persist.

    Interpretation also depends on the distinction between association and mechanism. Proteomic enrichment identifies candidate corona components; pre-incubation experiments test selected proteins; uptake, trafficking, and expression provide functional readouts. The reported apolipoprotein E result links higher uptake and lysosomal trafficking with unchanged expression, but further work would be needed to determine the causal contribution of each intracellular step. The dissertation abstract also does not provide all experimental parameters or effect sizes, so exact replication should rely on the full methods rather than inferred settings.

    Why this cross-domain matters, maturity, and limitations

    The dissertation places mammalian LNP delivery alongside agricultural nanoparticle sensing to emphasize a shared principle: biological surroundings can alter nanoparticle behavior. The plant-focused discussion is valuable as a translational perspective, but it should not be conflated with the LNP experiments in human plasma and HepG2 cells. Plant systems present distinct biological barriers and nanoparticle-proteomics challenges, as the dissertation notes; the mammalian findings do not validate a particular plant-sensor design. The cross-domain lesson is therefore methodological rather than a claim of identical mechanisms: characterize the particle–environment interface in the system where the technology will be used, then test function with domain-appropriate readouts.

    Research Support Resources

    For related mRNA delivery and transfection studies, researchers may use EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010) as a reporter for a translation efficiency assay while fluorescent labeling supports tracking of the RNA. This 5-moUTP modified mRNA provides complementary fluorescence and luciferase readouts, including for workflows involving in vivo bioluminescence imaging; these capabilities support assay development but do not reproduce or independently validate the dissertation’s protein-corona findings.